DMK Pharmaceuticals (DMKPQ)
OTHER OTC:DMKPQ
Holding DMKPQ?
Track your performance easily

DMK Pharmaceuticals (DMKPQ) Financial Statements

1,117 Followers

DMK Pharmaceuticals Financial Overview

DMK Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-9.18; its P/E ratio is >-0.01; DMK Pharmaceuticals is scheduled to report earnings on November 12, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 9.06K$ 6.95K$ 1.45M$ 2.06M$ 1.51M
Gross Profit$ -329.43K$ -354.45K$ -335.07K$ -331.11K$ -141.90K
EBIT$ -1.71M$ -6.96M$ -9.01M$ -3.94M$ -4.27M
EBITDA$ -1.64M$ -6.87M$ -8.91M$ -3.57M$ -3.87M
Net Income Common Stockholders$ -1.39M$ -8.57M$ 6.82M$ -3.33M$ -4.40M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.66M$ 670.34K$ 3.13M$ 1.11M$ 2.42M
Total Assets$ 8.96M$ 4.75M$ 9.08M$ 10.93M$ 12.14M
Total Debt$ 63.21K$ 157.25K$ 250.36K$ 342.56K$ 432.02K
Net Debt$ -6.60M$ -513.10K$ -2.88M$ -768.87K$ -1.99M
Total Liabilities$ 13.92M$ 16.57M$ 18.60M$ 11.58M$ 9.29M
Stockholders Equity$ -5.29M$ -11.83M$ -9.68M$ -808.07K$ 2.85M
Cash Flow-
Free Cash Flow$ -3.74M$ -2.57M$ -1.54M$ 2.43M$ -7.71M
Operating Cash Flow$ -3.74M$ -2.57M$ -1.55M$ -1.57M$ -7.50M
Investing Cash Flow$ 1.77M$ 138.29K$ 841.78K$ 81.86K$ 779.22K
Financing Cash Flow$ 7.96M$ 750.00$ 2.72M-$ 285.00K
Currency in USD

DMK Pharmaceuticals Earnings and Revenue History

DMK Pharmaceuticals Debt to Assets

DMK Pharmaceuticals Cash Flow

DMK Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis